L'union medicale du Canada最新文献

筛选
英文 中文
[Focus on smoking]. [关注吸烟]。
L'union medicale du Canada Pub Date : 1994-01-01
M Gagné, A Gervais, M Juneau, R Laforte, C Lemoine, G Ostiguy, D Perreault, M Robitaille, J Taillefer, M Xhignesse
{"title":"[Focus on smoking].","authors":"M Gagné, A Gervais, M Juneau, R Laforte, C Lemoine, G Ostiguy, D Perreault, M Robitaille, J Taillefer, M Xhignesse","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19100751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The skeleton: a true bazaar!]. 骷髅:一个真正的集市!
L'union medicale du Canada Pub Date : 1994-01-01
R Henry
{"title":"[The skeleton: a true bazaar!].","authors":"R Henry","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19100750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Initial empiric treatment of pneumonia and the new antibiotics]. [肺炎的初步经验性治疗及新型抗生素]。
L'union medicale du Canada Pub Date : 1994-01-01
M Parent
{"title":"[Initial empiric treatment of pneumonia and the new antibiotics].","authors":"M Parent","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19100745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Update on inhalation therapy in asthma and obstructive bronchopulmonary diseases]. [哮喘和阻塞性支气管肺疾病吸入疗法的最新进展]。
L'union medicale du Canada Pub Date : 1994-01-01
L P Boulet, P d'Amours, D Bérubé, M Rouleau, J G Parent, C Pelletier, C Touchette
{"title":"[Update on inhalation therapy in asthma and obstructive bronchopulmonary diseases].","authors":"L P Boulet,&nbsp;P d'Amours,&nbsp;D Bérubé,&nbsp;M Rouleau,&nbsp;J G Parent,&nbsp;C Pelletier,&nbsp;C Touchette","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Significant changes have occurred in aerosol therapy in the last few years. New devices have been developed to facilitate the administration of bronchodilator or anti-inflammatory drugs into the airways. Metered-dose inhaler with or without a spacer or powder devices are now considered the ideal mode of administration of aerosolized medications in the regular treatment of child or adult asthma as well as in COPD. In mild to moderate acute asthma, bronchodilators are ideally administered with a metered dose inhaler with a spacer device, nebulisation being required in only a minority of patients. Powder devices such as the Turbuhaler may also be useful in acute asthma but inspiratory flow should be sufficient, and their usefulness in this context remains to be better determined. In severe acute asthma or in patients unable to properly use the other inhalation devices, nebulisation can be used, with oxygen in the case of acute asthma. In patients requiring mechanical ventilation, administration of bronchodilators can be done with a metered-dose inhaler with a spacer device specifically designed for this purpose: it will replace nebulisation in most cases. In young children and infants unable to use spacer devices with a mouthpiece (< 5 years), wet nebulisation is still used during acute attacks of asthma. In these circumstances, the use of metered-dose inhalers with a spacer and mask are probably appropriate in some children but further studies are required to recommend their use.</p>","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19100747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[From Lorenzo's oil to myelin]. [从洛伦佐的油到髓磷脂]。
L'union medicale du Canada Pub Date : 1994-01-01
A Merminod, B Lemieux
{"title":"[From Lorenzo's oil to myelin].","authors":"A Merminod,&nbsp;B Lemieux","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19100749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The treatment of acromegaly]. 肢端肥大症的治疗。
L'union medicale du Canada Pub Date : 1993-11-01
H Beauregard, M Somma, E Rasio, O Serri, N Aris-Jilwan, R Comtois, H Long, T Abribat, A Boucher, J Hardy
{"title":"[The treatment of acromegaly].","authors":"H Beauregard,&nbsp;M Somma,&nbsp;E Rasio,&nbsp;O Serri,&nbsp;N Aris-Jilwan,&nbsp;R Comtois,&nbsp;H Long,&nbsp;T Abribat,&nbsp;A Boucher,&nbsp;J Hardy","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Acromegaly is a rare disease which can significantly reduce life expectancy. Clinical features are diverse and the patient may consult a variety of medical and surgical specialists before the diagnosis is suspected. However, the disease is easily confirmed by the appropriate laboratory tests, namely GH and IGF1 measurements. In most cases, acromegaly is secondary to a micro or macrosomatotrope pituitary adenoma. Those lesions are easily visualized by a pituitary CT Scan or Magnetic Resonance Imaging. Visual fields have to be evaluated by a neuro-ophthalmologist, and a thorough evaluation of other pituitary functions have to be performed. Selective removal of the adenoma by the transsphenoidal route is the treatment of choice for acromegaly. When performed by an experienced neurosurgeon, normalization of GH secretion can be expected in approximately 75% of cases. The surgical outcome is modulated by the volume, the extension of the tumor and the preoperative GH level. Octreotide, radiotherapy or bromocriptine are indicated whenever the patient remains with an elevated level of GH with persistency of symptoms.</p>","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19291903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research in psychiatry]. [精神病学研究]。
L'union medicale du Canada Pub Date : 1993-11-01
Y Lamontagne, A Lesage
{"title":"[Research in psychiatry].","authors":"Y Lamontagne,&nbsp;A Lesage","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The department of psychiatry of the Université de Montréal has now organized a well structured research network in the area of child, adult and forensic psychiatry. The authors summarize the scientific approach according to research in these different sectors and believe that, although research in psychiatry now tends to promote diagnostic and treatment methods based more and more on neuro-sciences, it does not neglect the contribution of psychosocial and clinical aspects without which the human dimensions of mental illness and the objective of improvement of care to patients would be rapidly forgotten on behalf of disembodied research projects completely deprived of the relation with patients.</p>","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19291935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[New treatment strategies in coronary disease]. [冠心病的新治疗策略]。
L'union medicale du Canada Pub Date : 1993-11-01
M G Bourassa
{"title":"[New treatment strategies in coronary disease].","authors":"M G Bourassa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The mortality associated with coronary atherosclerosis has decreased by 30% to 40% in the last few decades. This reduction has followed major pharmacological and biotechnological advances and can possibly be attributed to better management of risk factors for coronary atherosclerosis and to more effective therapy of its late manifestations. Nevertheless, the coronary artery disease remains a major public health problem. It is responsible for 40% to 45% of deaths in our population and, although it becomes manifest later than previously, its incidence and prevalence may not have declined significantly. Recent studies suggest that progression of coronary atherosclerosis can be delayed, that regression can also occur, and that this can lead to a reduction in morbidity and mortality. Several types of interventions have been performed in these studies. Some of them such as a drastic modification in lifestyle, the administration of one or several hypocholesterolemic agents or partial ileal bypass have achieved these results by markedly lowering LDL or raising HDL cholesterol. Other manipulations of plasma lipoproteins are also possible, such as the administration of specific protein or enzyme inhibitors, anti-oxidants and omega-3 fatty acids. Calcium antagonists and possibly angiotensin converting-enzyme inhibitors slow the progression of early coronary lesions and prevent the appearance of new lesions. These interventions, in addition to influencing the size of the atherosclerotic plaque, can have other important effects. They can contribute to the preservation of integrity and function of endothelial cells.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19291895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Renal transplantations: current reality and future challenges]. [肾移植:当前的现实和未来的挑战]。
L'union medicale du Canada Pub Date : 1993-11-01
G St-Louis
{"title":"[Renal transplantations: current reality and future challenges].","authors":"G St-Louis","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Kidney transplantation is a well recognized form of treatment for end-stage renal failure patients. Transplanted patients can hope for a prolonged and productive life. Many factors are responsible for the improvement of kidney transplantation over the last years. Despite its progress and success, many limitations still exist: shortage of kidney, humoral hypersensitivity or recipients, side effects of immunosuppressive medication and chronic rejection. Will the induction of specific tolerance to xenograft, with the help of transgenic biology, be the solution of tomorrow?</p>","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19291897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chemoprevention of lung cancer]. 肺癌的化学预防。
L'union medicale du Canada Pub Date : 1993-11-01
J Ayoub, Y Ying, W E Bradley
{"title":"[Chemoprevention of lung cancer].","authors":"J Ayoub,&nbsp;Y Ying,&nbsp;W E Bradley","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Chemoprevention, or pharmacological intervention in healthy individuals at risk of developing cancer, is attracting attention as a potential tool in cancer prevention. Lung cancer, with its high incidence and poor prognosis, is a particularly interesting disease for these studies. The retinoids are a promising group of chemopreventive agents, since they are involved in growth control and are a necessary cofactor for proper activity of a protein receptor which we have shown to be a lung cancer suppressor. Nevertheless, the toxic side effects of retinoids at pharmacological dose present difficulties and current studies are aimed at determining the efficacy of various forms of retinoids and chemoprevention protocols in the target populations.</p>","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19291940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信